Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Steven M. Ansell"'
The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
Autor:
Sean C. Semple, Xinyao Du, Barbara L. Mui, Akin Akinc, Muthusamy Jayaraman, Roy van der Meel, Jayesh A. Kulkarni, Martin Maier, Thomas D. Madden, Scott A Barros, Kevin Fitzgerald, Pieter R. Cullis, Muthiah Manoharan, Steven M. Ansell, Marco A. Ciufolini, Ying K. Tam, Michael J. Hope, Dominik Witzigmann
Publikováno v:
Nature Nanotechnology, 14(12), 1084-1087. Nature Publishing Group
The regulatory approval of Onpattro, a lipid nanoparticle-based short interfering RNA drug for the treatment of polyneuropathies induced by hereditary transthyretin amyloidosis, paves the way for clinical development of many nucleic acid-based therap
Autor:
Barbara L Mui, Ying K Tam, Muthusamy Jayaraman, Steven M Ansell, Xinyao Du, Yuen Yi C Tam, Paulo JC Lin, Sam Chen, Jayaprakash K Narayanannair, Kallanthottathil G Rajeev, Muthiah Manoharan, Akin Akinc, Martin A Maier, Pieter Cullis, Thomas D Madden, Michael J Hope
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 2, Iss C (2013)
Lipid nanoparticles (LNPs) encapsulating short interfering RNAs that target hepatic genes are advancing through clinical trials, and early results indicate the excellent gene silencing observed in rodents and nonhuman primates also translates to huma
Externí odkaz:
https://doaj.org/article/f5677ebf4c334dbe9c9d38a4979393bb
Autor:
Steven M. Ansell, Douglas H. Adamson, Robert K. Prud'homme, Lawrence D. Mayer, Walid Saad, Adam R. Wohl, John J. Squiers, Christopher W. Macosko, Suzanne M. D'Addio, Thomas R. Hoye, Christine Vauthier, Margarita Herrera-Alonso
Publikováno v:
Journal of Controlled Release. 162:208-217
Drug nanocarrier clearance by the immune system must be minimized to achieve targeted delivery to pathological tissues. There is considerable interest in finding in vitro tests that can predict in vivo clearance outcomes. In this work, we produce nan
Autor:
Ghania Chikh, Laura Sekirov, Jennifer Takasaki, Steven M. Ansell, Sameersingh G. Raney, Ying Tam, Irina Brodsky
Publikováno v:
Bioconjugate Chemistry. 17:451-458
A mixture of ionizable cationic lipids, steric barrier lipids, and colipids is used to encapsulate oligonucleotide DNA in lipidic particles called SALP. This material is under development as an adjuvant for vaccines. Previously we have shown that cou
Autor:
Michael J. Hope, Kathy A Clow, Steven M. Ansell, Sandra K. Klimuk, Sean C. Semple, Troy Harasym
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 312:1020-1026
Polyethylene glycol (PEG) is used widely in the pharmaceutical industry to improve the pharmacokinetics and reduce the immunogenicity of therapeutic and diagnostic agents. The incorporation of lipid-conjugated PEG into liposomal drug delivery systems
Publikováno v:
Bioconjugate Chemistry. 11:14-21
A series of oligomers of polyamides based on 14-amino-3,6,9, 12-tetraoxatetradecanoic acid monomers (ATTAn) was synthesized. These materials were designed as monodisperse analogues of poly(ethylene glycol) for use in biomedical applications where rep
Autor:
Dora K. Lee, Laura Sekirov, Ljiljana D. Kojic, Steven M. Ansell, Anthony Boey, Nancy Dos Santos, Sandra K. Klimuk, Troy Harasym, Sean C. Semple, Janet S. Hankins, Athena R. Bennett
Publikováno v:
Bioconjugate Chemistry. 10:653-666
Lipid conjugates of oligo-(14-amino-3,6,9,12-tetraoxatetradecanoic acid) (ATTAn) were synthesized as monodisperse analogues of poly(ethylene glycol) (PEG) derivatives used in liposomal drug delivery systems. The new lipids were shown to be at least e
Publikováno v:
Archives of Biochemistry and Biophysics. 357:185-194
Complement activation causes opsonization of foreign particles leading to particle elimination from the blood. Complement-mediated opsonization of charged and large liposomes presents a fundamental problem in their use to deliver therapeutic agents i
Publikováno v:
Journal of Liposome Research. 7:331-361
The prospects for developing improved liposome based anti-cancer drug formulations are great, particularly when considering the potential role of lipid-based formulations for delivery of biopharmaceuticals. It is important however, to pursue improved
Publikováno v:
Bioconjugate Chemistry. 7:490-496
Liposome antibody conjugates are potentially useful as a means of targeting drugs to specific tissues. A new protocol for the conjugation of IgG to maleimide-containing liposomes was developed using 3-(2-pyridyldithio)propionic acid hydrazide (PDPH)